RUSSO, Pierluigi
RUSSO, Pierluigi
Mostra
prodotti
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.003 secondi).
Cost-effectiveness of direct acting oral anticoagulants in the prevention of thromboembolic complications. Limits and concerns of economic evaluations
2019 Russo, P.; Rosano, G. M. C.; Favato, G.; Staniscia, T.; Romano, F.
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)
2020 Breccia, Massimo; Olimpieri, PIER PAOLO; Olimpieri, Odoardo; Pane, Fabrizio; Iurlo, Alessandra; Foggi, Paolo; Cirilli, Alessia; Colatrella, Antonietta; Cuomo, Marcello; Gozzo, Lucia; Summa, Valentina; Corradini, Paolo; Russo, Pierluigi; Monitoring Registries Group, Aifa’S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cost-effectiveness of direct acting oral anticoagulants in the prevention of thromboembolic complications. Limits and concerns of economic evaluations | 2019 | Russo, P.; Rosano, G. M. C.; Favato, G.; Staniscia, T.; Romano, F. | |
| How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA) | 2020 | Breccia, Massimo; Olimpieri, PIER PAOLO; Olimpieri, Odoardo; Pane, Fabrizio; Iurlo, Alessandra; Foggi, Paolo; Cirilli, Alessia; Colatrella, Antonietta; Cuomo, Marcello; Gozzo, Lucia; Summa, Valentina; Corradini, Paolo; Russo, Pierluigi; Monitoring Registries Group, Aifa’S |